Over the past 12 months, 0 insiders at CinCor Pharma, Inc. filed 0 open-market SEC Form 4 transactions on CINC: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 28, 22 | James HealyDirector,TenPercentOwner | SELL | 6.0K | $14.32 | $86K |
| Aug 15, 22 | 5am Partners Vi, LlcTenPercentOwner | BUY | 487.3K | $30.00 | $14.6M |
| Aug 15, 22 | Sofinnova Partners SasTenPercentOwner | BUY | 133.3K | $30.00 | $4.0M |
| Aug 11, 22 | Gap Coinvestments Iii, LlcTenPercentOwner | BUY | 83.0K | $30.00 | $2.5M |
| Aug 11, 22 | L.p. General Atlantic Genpar (bermuda)TenPercentOwner | BUY | 83.0K | $30.00 | $2.5M |
| Aug 11, 22 | James HealyDirector,TenPercentOwner | BUY | 500.0K | $30.00 | $15.0M |
| Aug 11, 22 | Sofinnova Management X, L.l.c.TenPercentOwner | BUY | 500.0K | $30.00 | $15.0M |
| Jun 10, 22 | Mason FreemanChief Medical Officer | SELL | 6 | $15.21 | $91 |
| Jan 11, 22 | Mary Theresa CoelhoEVP CFO & Chief BD Officer | BUY | 100 | $16.00 | $2K |
| Jan 11, 22 | Mason FreemanEVP Clinical Development | BUY | 2.5K | $16.00 | $40K |
| Jan 11, 22 | Gap Coinvestments Iii, LlcTenPercentOwner | BUY | 1.70M | $16.00 | $27.2M |
| Jan 11, 22 | L.p. General Atlantic Genpar (bermuda)TenPercentOwner | BUY | 1.70M | $16.00 | $27.2M |
| Jan 11, 22 | James HealyDirector,TenPercentOwner | BUY | 325.0K | $16.00 | $5.2M |
| Jan 11, 22 | Kush ParmarTenPercentOwner | BUY | 312.5K | $16.00 | $5.0M |
| Jan 11, 22 | Catherine PearceChief Operating Officer | BUY | 1.5K | $16.00 | $24K |
| Jan 11, 22 | Sofinnova Capital IxTenPercentOwner | BUY | 220.0K | $16.00 | $3.5M |
| Jan 11, 22 | Sofinnova Venture Partners X, L.p.TenPercentOwner | BUY | 325.0K | $16.00 | $5.2M |
| Jan 11, 22 | Garidel Marc DeChief Executive Officer | BUY | 12.5K | $16.00 | $200K |
Over the past 12 months, insiders at CinCor Pharma, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CINC, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market CINC insider purchase in our data was $27.2M by Gap Coinvestments Iii, Llc, TenPercentOwner, filed on Jan 11, 22.
0 different insiders at CinCor Pharma, Inc. filed open-market SEC Form 4 transactions on CINC over the last 12 months.
InsiderTape plots every CINC insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every CinCor Pharma, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →